Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Posaconazole double-layer osmotic pump controlled release tablet and preparation method thereof

A posaconazole double-layer, osmotic pump controlled release technology, applied in pharmaceutical formulations, medical preparations with inactive ingredients, and medical preparations containing active ingredients, etc. It can avoid the fluctuation of blood drug concentration, good correlation between in vitro and in vivo, and stable blood drug concentration.

Inactive Publication Date: 2014-07-30
JINAN KANGHE MEDICAL TECH
View PDF3 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The currently marketed products are posaconazole suspension and posaconazole sustained-release tablets, but posaconazole suspension has the disadvantages of poor stability, large oral dose and low bioavailability. Bioavailability (8-47%), further improvement depends on whether it is taken together with high-fat food; from the patent PCT / US2009 / 040652 and the instruction document of posaconazole sustained-release tablets, it can be known that posaconazole sustained-release tablets are prepared by heating Solvent extrusion technology pre-forms posaconazole and hydroxypropyl methylcellulose acetate succinate polymer into solid dispersion form, and then makes sustained-release tablets, which requires special and expensive hot-melt extrusion equipment, The preparation process is complicated, the production cost is high, and it is not suitable for industrialized large-scale production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Posaconazole double-layer osmotic pump controlled release tablet and preparation method thereof
  • Posaconazole double-layer osmotic pump controlled release tablet and preparation method thereof
  • Posaconazole double-layer osmotic pump controlled release tablet and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0053] Preparation Process:

[0054] 1) Posaconazole pretreatment

[0055] The posaconazole raw material is ultrafinely pulverized, with an average particle size of 0.5-10 μm;

[0056] 2) Preparation of drug-containing layer particles

[0057] Mix posaconazole superfine powder, polyoxyethylene with a molecular weight of 100,000-2 million, an osmotic pressure active substance, and an adhesive in a mixer to obtain drug-containing layer particles, add a lubricant, and set aside;

[0058] 3) Preparation of booster layer particles

[0059] Polyoxyethylene with a molecular weight of 4-8 million, osmotic pressure active substances, and colorants are wet-granulated with 70% ethanol solution, and dried in a fluidized bed, but not limited to a fluidized bed, to obtain booster layer granules, and lubricants are added. spare;

[0060] 4) Preparation of double-layer tablet core

[0061] A double-layer tablet press is used to compress the posaconazole double-layer tablet. First, the dr...

Embodiment 2

[0067] Preparation process: (same as Example 1)

Embodiment 3

[0069] Preparation process: (same as Example 1)

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle sizeaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the field of medicinal preparation and specifically provides a posaconazole double-layer osmotic pump controlled release tablet and a preparation method thereof. The tablet comprises a tablet core and a semipermeable controlled release film. The tablet core comprises a drug containing layer and a boosting layer. The drug containing layer is located inside the controlled release film which is provided with a drug releasing hole. The boosting layer is located inside the controlled release film at a place far away from the drug releasing hole. One end of the water-permeable controlled release film is provided with one or more drug releasing holes. The release curve of the preparation drug shows a zero-order release pattern, and thus the problem of drug resistance caused by long-term use of posaconazole dosage forms on the market is solved. Besides, the problems that the preparation technology is complex, the preparation cost is high, and the drug is unsuitable for industrialized mass production due to the adoption of a hot-melt extrusion technology are solved. Simultaneously, the in vivo-in vitro correlation of the drug is better ensured and the clinical monitoring of plasma concentration is better facilitated.

Description

technical field [0001] The invention relates to the field of pharmaceutical preparations, in particular to a posaconazole double-layer osmotic pump controlled-release tablet and a preparation method thereof. Background technique [0002] Schering-Plough's triazole antifungal drug posaconazole (trade name Noxafil) for the prevention of invasive Aspergillus (Aspergillus) and Candida (Candida) infections has been approved for marketing. The US FDA approved the drug for immunocompromised patients over 13 years old, especially hematopoietic stem cell transplant recipients with graft versus host disease (GVHD), blood cancer patients, and long-term leukopenia due to chemotherapy of patients. Posaconazole is the first antifungal drug approved for the prevention of invasive Aspergillus infections. The research results show that the effect of the drug on preventing Aspergillus infection is stronger than that of fluconazole (fluconazole), and its molecular structure is as follows: ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/36A61K31/496A61K47/38A61K47/34A61P31/10
Inventor 张颖刘元鑫刘鹏曲延伟赫红王学斌杨延昆朱玉正
Owner JINAN KANGHE MEDICAL TECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products